Cargando…
New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown
The 2020s began with a rare coronavirus (COVID-19) disaster, which led to a pandemic-induced recession and Great Lockdown. In response, there has been a worldwide mobilization of resources to detect, treat, and cure the virus. Some policymakers are advocating for the repatriation of globally distrib...
Autores principales: | Dunlap, Denise, Santos, Roberto S., McManus, David D., Buchholz, Bryan O., Hafer, Nathaniel S., Picard, MaryAnn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372191/ https://www.ncbi.nlm.nih.gov/pubmed/34413924 http://dx.doi.org/10.46697/001c.17692 |
Ejemplares similares
-
On deglobalization in quantum chromodynamics
por: Dasgupta, Mrinal
Publicado: (2003) -
The Ideal of Global Philosophy in an Age of Deglobalization
por: Symons, John
Publicado: (2023) -
A multi-institutional partnership catalyzing the commercialization of medical devices and biotechnology products
por: Hafer, Nathaniel, et al.
Publicado: (2021) -
Point-of-care testing, your cardiologist, and affairs of the heart
por: Dunlap, Denise, et al.
Publicado: (2021) -
COVID-19: a gray swan’s impact on the adoption of novel medical technologies
por: Dunlap, Denise R., et al.
Publicado: (2022)